USA - NASDAQ:AKAN - CA00971M5028 - Common Stock
The current stock price of AKAN is 1.465 USD. In the past month the price decreased by -37.66%. In the past year, price decreased by -71.06%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 41.24 | 858.31B | ||
| JNJ | JOHNSON & JOHNSON | 18 | 450.02B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.48 | 254.34B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.97 | 242.00B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 12.53 | 214.40B | ||
| MRK | MERCK & CO. INC. | 9.52 | 209.46B | ||
| PFE | PFIZER INC | 7.17 | 138.16B | ||
| SNY | SANOFI-ADR | 11.24 | 119.68B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.95 | 92.80B | ||
| GSK | GSK PLC-SPON ADR | 7.71 | 94.17B | ||
| ZTS | ZOETIS INC | 20.01 | 55.16B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 193.71 | 42.83B |
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
AKANDA CORP
1A, 1B Learoyd Road
New Romney GB
Employees: 5
Phone: 442034889514
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
The current stock price of AKAN is 1.465 USD. The price decreased by -6.69% in the last trading session.
AKAN does not pay a dividend.
AKAN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
AKANDA CORP (AKAN) has a market capitalization of 1.07M USD. This makes AKAN a Nano Cap stock.
ChartMill assigns a fundamental rating of 2 / 10 to AKAN. Both the profitability and financial health of AKAN have multiple concerns.
Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -12.28. The EPS increased by 99.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.76% | ||
| ROE | -95.78% | ||
| Debt/Equity | 0.08 |